Evaluation of biomarkers for clinical activity of systemic lupus erhythematodes

The scope of the present clinical study is to conduct research on biomarkers of clinical activity of SLE (Human IFN-gamma, Human IFN-alpha, Human sICAM-1, Human sVCAM-1, Human sIL-2R, and TNF-R) and to determine the connection between laboratory biomarkers and clinical and immunological activity of...

Full description

Saved in:
Bibliographic Details
Main Authors: Valentina Reshkova, Dobroslav Kyurkchiev, Simeon Monov
Format: Article
Language:English
Published: Pensoft Publishers 2025-01-01
Series:Pharmacia
Online Access:https://pharmacia.pensoft.net/article/132051/download/pdf/
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832589803297701888
author Valentina Reshkova
Dobroslav Kyurkchiev
Simeon Monov
author_facet Valentina Reshkova
Dobroslav Kyurkchiev
Simeon Monov
author_sort Valentina Reshkova
collection DOAJ
description The scope of the present clinical study is to conduct research on biomarkers of clinical activity of SLE (Human IFN-gamma, Human IFN-alpha, Human sICAM-1, Human sVCAM-1, Human sIL-2R, and TNF-R) and to determine the connection between laboratory biomarkers and clinical and immunological activity of the disease. In the present study, we included 48 patients with SLE (43 women and 5 men) age 53 years, with an average value of 4.32 points (min 0 max 12 points) of activity of SLE by SLEDAI-2K, and 34 healthy controls (31 women and 3 men). Basic clinical symptoms include arthritis and skin damage. The analysis of biomarkers in serum is statistically significantly higher than healthy controls for human IFN-alpha and human sVCAM-1. The analysis of biomarkers in the serum of human IFN-gamma, human sICAM-1, TNF-R, and human IL-12p40/p70 is not statistically significantly higher than healthy controls. The correlation analysis between disease activity assessed with SLEDAI-2K and biomarkers did not confirm a statistically significant relationship. Conclusion. Human IFN-alpha and human sVCAM-1 are sensitivity markers and play an important role in the activity of the disease in the Bulgarian population with SLE.
format Article
id doaj-art-de862b547af2474cbb9a8f62da28e80f
institution Kabale University
issn 2603-557X
language English
publishDate 2025-01-01
publisher Pensoft Publishers
record_format Article
series Pharmacia
spelling doaj-art-de862b547af2474cbb9a8f62da28e80f2025-01-24T08:33:28ZengPensoft PublishersPharmacia2603-557X2025-01-01721610.3897/pharmacia.72.e132051132051Evaluation of biomarkers for clinical activity of systemic lupus erhythematodesValentina Reshkova0Dobroslav Kyurkchiev1Simeon Monov2University Hospital “St. Ivan Rilski”University Hospital “St. Ivan Rilski”University Hospital “St. Ivan Rilski”The scope of the present clinical study is to conduct research on biomarkers of clinical activity of SLE (Human IFN-gamma, Human IFN-alpha, Human sICAM-1, Human sVCAM-1, Human sIL-2R, and TNF-R) and to determine the connection between laboratory biomarkers and clinical and immunological activity of the disease. In the present study, we included 48 patients with SLE (43 women and 5 men) age 53 years, with an average value of 4.32 points (min 0 max 12 points) of activity of SLE by SLEDAI-2K, and 34 healthy controls (31 women and 3 men). Basic clinical symptoms include arthritis and skin damage. The analysis of biomarkers in serum is statistically significantly higher than healthy controls for human IFN-alpha and human sVCAM-1. The analysis of biomarkers in the serum of human IFN-gamma, human sICAM-1, TNF-R, and human IL-12p40/p70 is not statistically significantly higher than healthy controls. The correlation analysis between disease activity assessed with SLEDAI-2K and biomarkers did not confirm a statistically significant relationship. Conclusion. Human IFN-alpha and human sVCAM-1 are sensitivity markers and play an important role in the activity of the disease in the Bulgarian population with SLE.https://pharmacia.pensoft.net/article/132051/download/pdf/
spellingShingle Valentina Reshkova
Dobroslav Kyurkchiev
Simeon Monov
Evaluation of biomarkers for clinical activity of systemic lupus erhythematodes
Pharmacia
title Evaluation of biomarkers for clinical activity of systemic lupus erhythematodes
title_full Evaluation of biomarkers for clinical activity of systemic lupus erhythematodes
title_fullStr Evaluation of biomarkers for clinical activity of systemic lupus erhythematodes
title_full_unstemmed Evaluation of biomarkers for clinical activity of systemic lupus erhythematodes
title_short Evaluation of biomarkers for clinical activity of systemic lupus erhythematodes
title_sort evaluation of biomarkers for clinical activity of systemic lupus erhythematodes
url https://pharmacia.pensoft.net/article/132051/download/pdf/
work_keys_str_mv AT valentinareshkova evaluationofbiomarkersforclinicalactivityofsystemiclupuserhythematodes
AT dobroslavkyurkchiev evaluationofbiomarkersforclinicalactivityofsystemiclupuserhythematodes
AT simeonmonov evaluationofbiomarkersforclinicalactivityofsystemiclupuserhythematodes